SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Haoxi Health Technology Limited (HAO) trades at a trailing P/E of 0.8. Trailing earnings yield is 125.08%. Graham Number is $13.44.
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (0.8); earnings yield beats bond yields (125.08%).
- Trailing Earnings Yield 125.08% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 70/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — HAO
Valuation Multiples
P/E (TTM)0.8
Forward P/EN/A
PEG Ratio0.00
Forward PEGN/A
P/B Ratio0.18
P/S Ratio0.24
EV/EBITDA0.3
Per Share Data
EPS (TTM)$1.34
Book Value / Share$6.00
Revenue / Share$11.33
FCF / Share$-1.16
Yields & Fair Value
Earnings Yield125.08%
Dividend Yield0.00%
Graham Number$13.44
SharesGrow IV$58.82 (+5151.8%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2021 |
4,341.2 |
0.00 |
-683.58 |
102.74 |
- |
| 2022 |
5,396.9 |
-269.84 |
-900.60 |
81.70 |
- |
| 2023 |
1,503.5 |
5.64 |
930.72 |
51.65 |
- |
| 2024 |
1,215.3 |
1.10 |
139.26 |
32.35 |
- |
| 2025 |
0.8 |
0.01 |
0.17 |
0.09 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2020 |
$0.01 |
$12.85M |
$304.07K |
2.4% |
| 2021 |
$0.01 |
$16.16M |
$244.59K |
1.5% |
| 2022 |
$0.03 |
$28.23M |
$969.75K |
3.4% |
| 2023 |
$0.04 |
$48.52M |
$1.29M |
2.7% |
| 2025 |
$1.32 |
$32.8M |
$3.88M |
11.8% |
